1Stejskal D,Proskova J,Adamovska S,et al.Preliminary experience with resistinassessment in common Population[J].Biomed Pap Med Facunivpalacky Olomouc CzechRepub,2002,146:47-49.
2Schutte R,Huisman HW, Schutte AE, et al. Leptin is independently associated with systolic blood pressure, pulse pressure and arterial compliance in hypertensive African women with increased adiposity:the POWIRS study[ J ]. Hum Hypertens, 2005,19:535-541.
3Sieminska L, Marek B, Kos-Kudla B, et al. Serum adiponectin in women with polycystic ovarian syndrome and its relation to clinical metabolic and endocrine parameters [ J ]. Endocrinol Invest,2004,27 : 528 -534.
4Qi Y,Takahashi N, Hileman SM, et al. Adiponectin acts in the brain to decrease body weight[ J ]. Nat Med ,2004,10 ( 5 ) :524-529.
5Tanida M ,Iwashita S,Terui N,et al. Effect of peripheral administration of leptin on the renal sympathetic nerve activity in high-fat diet-related hypertensive rats [J]. Lif Sci,2006,78:1149-1154.
6Masaki T, Chiba S, Yasuda T, et al. Peripheral, but not central, administration of adiponectin reduces visceral adiposity and upregulates the expression of uncoupling protein in agouti yellow ( Ay/a ) obese mice [ J ]. Diabetes, 2003,52 : 2266- 2273.
7Gaukredger N,Mayosi BM,hnrie H,et al. A rare variant of the leptin gene bas large effects on blood pressure and carotid intima-medial thickness : a study of 1428 individuals in 248 families[J]. Med Genet,2005,42:474-478.
9Ouchi N, Ohishi M, Kihara S, et al. Association of hypoadiponectinemia with impaired vasoreaetivity [ J ]. Hypertension, 2003,42 ( 3 ) :231-234.
10Bahia L, Aguiar LG, Villela N, et al. Adiponectin is associated with improvement of endothelial function after rosiglitazone treatment in non-diabetic individuals with metabolic syndrome [ J ]. Atherosclerosis,2007,195 ( 1 ) : 138-146.
